C. Hatzara

Comparison of Two Gamma Interferon Release Assays and Tuberculin Skin Testing for Tuberculosis Screening in a Cohort of Patients with Rheumatic Diseases Starting Anti-Tumor Necrosis Factor Therapy

S. Tsikrika, D. Vassilopoulos, E. Hadziyannis, 2011, Clinical and Vaccine Immunology.

Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment

K. Thomas, D. Vassilopoulos, E. Hadziyannis, 2020, Pathogens & immunity.

Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases

D. Vassilopoulos, E. Hadziyannis, G. Georgiopoulos, 2014, Annals of the rheumatic diseases.

Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

D. Vassilopoulos, E. Hadziyannis, A. Kandili, 2012, Annals of the rheumatic diseases.

Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases

D. Vassilopoulos, E. Hadziyannis, G. Georgiopoulos, 2014, Annals of the Rheumatic Diseases.